Thomas (TJ) Carella, based in New York, joined Warburg Pincus in 2016 where he is a managing director and focused on health care investing.
Prior to joining Warburg Pincus, Mr. Carella was a partner in the Merchant Banking Division of Goldman Sachs and global head of the division’s private equity activities in the health care sector. While at Goldman Sachs, Mr. Carella led or was actively involved in investments including: Advanced Recovery Systems, Assuramed, Drayer Physical Therapy, Globus Medical, Golden State Medical Supply, iHealth Technologies, Magnacare, Press Ganey, Privia Health, T2Biosystems and Vitals Health.
Mr. Carella currently serves as a director on the boards of Alignment Healthcare, CityMD/Summit Medical Group, Polyplus Transfection, Vertice Pharma, WebPT, and public companies SOC Telemed (Nasdaq:TLMD) and Outset Medical (NASDAQ:OM). Mr. Carella previously served on the board of directors of T2 Biosystems, Inc. (NASDAQ:TTOO), where he served from March 2013 to March 2016.
Mr. Carella earned his Bachelor of Arts degree from Harvard College in 1997 and an MBA from Harvard Business School in 2004.
Current role